BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21298269)

  • 21. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus.
    Lahita RG; Rivkin E; Cavanagh I; Romano P
    Arthritis Rheum; 1993 Nov; 36(11):1566-74. PubMed ID: 8240433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases.
    Buttgereit F; Grünewald T; Schüler-Maué W; Burmester GR; Hiepe F
    Clin Rheumatol; 1997 Nov; 16(6):562-9. PubMed ID: 9456008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-annexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study.
    Horimoto AMC; de Jesus LG; de Souza AS; Rodrigues SH; Kayser C
    Adv Rheumatol; 2020 Jul; 60(1):38. PubMed ID: 32736594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticardiolipin antibodies in pathogenesis of infertility.
    Loncar D
    Vojnosanit Pregl; 2010 Mar; 67(3):216-9. PubMed ID: 20361696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus.
    Lang B; Straub RH; Weber S; Röther E; Fleck M; Peter HH
    Lupus; 1997; 6(8):652-5. PubMed ID: 9364424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
    J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.
    Sachse C; Lüthke K; Hartung K; Fricke M; Liedvogel B; Kalden JR; Peter HH; Lakomek HJ; Henkel E; Deicher H
    Rheumatol Int; 1995; 15(1):23-9. PubMed ID: 7652462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
    Saxena R; Sturfelt G; Nived O; Wieslander J
    Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
    Lakos G; Kiss E; Regeczy N; Tarjan P; Soltesz P; Zeher M; Bodolay E; Szucs G; Szakony S; Sipka S; Szegedi G
    J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus.
    Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Kobayashi S; Koike T
    Arthritis Rheum; 1996 Sep; 39(9):1466-74. PubMed ID: 8814057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
    Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE.
    Bagger PV; Andersen V; Baslund B; Beck B; Hove H; Høier-Madsen M; Petersen J; Philip J; Schaadt O; Skouby SO
    Acta Obstet Gynecol Scand; 1993 Aug; 72(6):465-9. PubMed ID: 8394626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Ikeda Y
    Am J Hematol; 1997 Mar; 54(3):209-13. PubMed ID: 9067499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.